The efficacy of colchicine in the management of coronavirus disease 2019
<h3>Background</h3><p dir="ltr">Severe acute respiratory syndrome coronavirus 2 (SARS-COV2) infection is a recently emerged viral infection causing predominantly mild upper respiratory symptoms. However, in some instances, it might result in acute respiratory distress syn...
محفوظ في:
| المؤلف الرئيسي: | Mohamed Nabil Elshafei (9960500) (author) |
|---|---|
| مؤلفون آخرون: | Ahmed Khalil (2132113) (author), Ahmed El-Bardissy (9960497) (author), Mohammed Danjuma (9960506) (author), Mohamed Badie Ahmed (10223510) (author), Mouhand F.H. Mohamed (16932579) (author) |
| منشور في: |
2020
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
The second wave of desaturation in coronavirus disease 2019
حسب: M.I. Alghizzawi (17280592)
منشور في: (2021) -
Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection
حسب: Mousa Ahmad Alhiyari (16932591)
منشور في: (2021) -
Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
حسب: Reem Hoteit (9929845)
منشور في: (2022) -
Kidney Transplant Recipients Infected With Coronavirus Disease 2019: Retrospective Qatar Experience
حسب: Mohamad M. Alkadi (14778640)
منشور في: (2021) -
Comparison of the clinical outcomes of non-invasive ventilation by helmet vs facemask in patients with acute respiratory distress syndrome
حسب: Mohamad Y. Khatib (11659459)
منشور في: (2021)